(Reuters) - Small startup NextCode Health will use gene-hunting tools pioneered by Iceland’s Decode Genetics to help a leading U.S. pediatric hospital identify causes of rare diseases in children, marking the latest foray of genetic sequencing into routine medical practice.
Cambridge, Massachusetts-based NextCode, a Decode spin-off, has signed a deal with Claritas, the former in-house lab of Boston Children’s Hospital that is now a stand-alone company focused exclusively on pediatric diagnostics, the companies told Reuters.
Hey, check out all the research scientist jobs. Post your resume today!
